AOD 9604 (Anti-Obesity Drug 9604) is the commercial development name given to the HGH fragment spanning amino acids 176 through 191, with a tyrosine substitution at the N-terminus replacing the native phenylalanine for stability
we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
On average, most people begin noticing positive effects within 2-4 weeks of consistent use
In a 23-week randomized clinical trial in humans, individuals taking AOD-9604 at 1 mg daily had an average of 2.8 kg weight reduction compared to a 0.8 kg weight reduction in those taking a placebo
Key Takeaways BPC-157 shows promising tissue healing, anti-inflammatory, and protective effects in animal studies, especially for musculoskeletal and gastrointestinal conditions123568
These experimental drugs came about to solve real problems